supp.fit

Fish Oil and Docosahexaenoic Acid: study protocols

89 study groups took Fish Oil together with Docosahexaenoic Acid. These are the doses the studies gave. They are not a recommendation.

Fish Oil: what the research found →

Dose per serving from research: Fish Oil

85 study groups in 73 studies say how much Fish Oil participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 g to 5 g, 33% of 85 study groups.

Daily doseStudy groups
250 mg or less
5
250 mg to 500 mg
1
500 mg to 1 g
12
1 g to 2.5 g
25
2.5 g to 5 g
28
5 g to 10 g
12
over 10 g
2

Dose per serving from research: Docosahexaenoic Acid

88 study groups in 76 studies say how much Docosahexaenoic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 33% of 88 study groups.

Daily doseStudy groups
100 mg or less
1
100 mg to 250 mg
13
250 mg to 500 mg
16
500 mg to 1 g
23
1 g to 2.5 g
29
2.5 g to 5 g
6

Commonly used together

77 of 89 study groups took Fish Oil and Docosahexaenoic Acid with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Omega-3 Fatty Acids
41
EPA
13
eicosapentaenoic acid (EPA)
12
Eicosapentaenoic Acid
10
Vitamin E
5

89 study groups

Study
Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity
2009 · fish-oil intervention group · Adults with metabolic syndrome; mean age 52.9 years; sex not specified
1 g120 mg26 weeks60
Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial
2012 · n-3 LCPUFA group · Pregnant women from Adelaide whose unborn baby had a mother, father, or sibling with a history of medically diagnosed allergic disease
1.5 g800 mg—368
An Exploratory Analysis of Changes in Mental Wellbeing Following Curcumin and Fish Oil Supplementation in Middle-Aged and Older Adults
2020 · FO group · Adults aged 50–80 years who were overweight or obese, sedentary, and without current major depression
2 g400 mg16 weeks31
An Exploratory Analysis of Changes in Mental Wellbeing Following Curcumin and Fish Oil Supplementation in Middle-Aged and Older Adults
2020 · FO + CUR group · Adults aged 50–80 years who were overweight or obese, sedentary, and without current major depression
2 g400 mg16 weeks30
Effects of Varied Omega-3 Fatty Acid Supplementation on Postpartum Mental Health and the Association between Prenatal Erythrocyte Omega-3 Fatty Acid Levels and Postpartum Mental Health
2023 · fish oil group · Healthy primiparous pregnant women aged 19–45 years
5.2 g400 mg12 weeks124
Long-chain PUFA supplementation in rural African infants: a randomized controlled trial of effects on gut integrity, growth, and cognitive development
2013 · fish-oil group · Gambian infants, approximately 3–9 months old, living in rural West Kiang; no specific diagnosed condition required
2 mL200 mg26 weeks87
Fish Oil And/Or Probiotics Intervention in Overweight/Obese Pregnant Women and Overweight Risk in 24-Month-Old Children
2023 · Fish oil + placebo · Pregnant women with overweight or obesity, enrolled before 18 gestational weeks; no chronic diseases stated
4.8 g3.8 g—82
Fish Oil And/Or Probiotics Intervention in Overweight/Obese Pregnant Women and Overweight Risk in 24-Month-Old Children
2023 · Probiotics + fish oil · Pregnant women with overweight or obesity, enrolled before 18 gestational weeks; no chronic diseases stated
4.8 g3.8 g—82
Long-Chain Polyunsaturated Fatty Acids, Homocysteine at Birth and Fatty Acid Desaturase Gene Cluster Polymorphisms are Associated with Children's Processing Speed up to Age 9 Years
2020 · FO · Healthy pregnant women; offspring were assessed at 7.5 and 9 years
150 mg500 mg—38
Long-Chain Polyunsaturated Fatty Acids, Homocysteine at Birth and Fatty Acid Desaturase Gene Cluster Polymorphisms are Associated with Children's Processing Speed up to Age 9 Years
2020 · FO + 5-MTHF · Healthy pregnant women; offspring were assessed at 7.5 and 9 years
150 mg500 mg—36
Effects of ω-3 PUFAs supplementation on myocardial function and oxidative stress markers in typical Rett syndrome
2014 · ω-3 PUFAs arm · Girls aged 12.7 ± 9.1 years on average with typical Rett syndrome and a demonstrated MeCP2 mutation
10 mL71.9 mg/kg1 year33
Effect of Docosahexaenoic Acid and Eicosapentaenoic Acid Supplementation on Sleep Quality in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Trial
2022 · DHA/EPA supplementation group · Healthy Japanese adults aged 45 years or older with poor sleep quality; male and female
2.88 g576 mg12 weeks33
Effects of omega-3 fatty acid supplementation on cigarette craving and oxidative stress index in heavy-smoker males: A double-blind, randomized, placebo-controlled clinical trial
2018 · fish-oil-derived omega-3 fatty acid supplements · heavy-smoker males who smoked at least 20 cigarettes per day
5 g600 mg90 days27
Fish oil supplementation alters emotion-generated corticolimbic functional connectivity in depressed adolescents at high-risk for bipolar I disorder: A 12-week placebo-controlled fMRI trial
2022 · FO group · Youth aged 9–21 years with major depressive disorder or Depressive Disorder NOS and a biological parent with bipolar I disorder
1.35 g780 mg12 weeks27
The effects of EPA and DHA enriched fish oil on nutritional and immunological markers of treatment naïve breast cancer patients: a randomized double-blind controlled trial
2017 · Fish oil group (FG) · Women aged 18–70 with newly diagnosed, treatment-naïve breast cancer before surgery
2 g780 mg30 days18
Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial
2013 · fish oil group · People with dry eye syndrome
1.25 g540 mg12 weeks15
Fish Oil Supplementation Increases Event-Related Posterior Cingulate Activation in Older Adults with Subjective Memory Impairment
2016 · Fish oil group · Older adults with subjective memory impairment, without mild cognitive impairment or dementia; age range and sex distribution not specified
2.4 g800 mg24 weeks15
Effects of omega-3 supplementation as an adjunct to non-surgical periodontal therapy on periodontal parameters in periodontitis patients: a randomized clinical trial
2022 · Intervention group · Adults aged 30–70 with stage II–IV, grade B periodontitis
1 g120 mg90 days15
Eicosapentaenoic and docosahexaenoic acids-rich fish oil supplementation attenuates strength loss and limited joint range of motion after eccentric contractions: a randomized, double-blind, placebo-controlled, parallel-group trial
2016 · EPA group · Healthy Japanese men, mean age 19.4 years; no stated diagnosed condition
2.4 g260 mg62 days12
Resting metabolic rate and skeletal muscle SERCA and Na(+) /K(+) ATPase activities are not affected by fish oil supplementation in healthy older adults
2020 · Fish oil group · Healthy physically active men and women aged 60–75 years
5 g1 g12 weeks12
Effect of eicosapentaenoic acids-rich fish oil supplementation on motor nerve function after eccentric contractions
2017 · EPA group · Healthy men, mean age 20.7 years; untrained and without a stated diagnosed condition
2.4 g260 mg62 days10
Omega-3 fatty acids enhance the beneficial effect of BCAA supplementation on muscle function following eccentric contractions
2022 · BCAA+FO group · Healthy, untrained men aged 19–20 years
2.4 g260 mg61 days10
The effect of fish oil supplementation on resistance training-induced adaptations
2023 · Fish Oil (FOS) · Adults aged 18–40, men and women, recreationally resistance-trained, without stated chronic disease
4.5 g1.58 g10 weeks10
Supplementation of eicosapentaenoic acid-rich fish oil attenuates muscle stiffness after eccentric contractions of human elbow flexors
2019 · EPA group · Healthy men, approximately 20–22 years old, without resistance training
2.4 g260 mg62 days8
Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes
2003 · n-3 PUFA diet · Elite athletes, including athletes with exercise-induced bronchoconstriction (EIB) and athletes without EIB; age and sex not reported
3.2 g2.2 g3 weeks5
Docosahexaenoic acid-rich fish oil improves heart rate variability and heart rate responses to exercise in overweight adults
2008 · Fish oil, no regular physical activity · Sedentary, overweight adults with risk factors for coronary disease
6 g1.56 g12 weeks—
Docosahexaenoic acid-rich fish oil improves heart rate variability and heart rate responses to exercise in overweight adults
2008 · Fish oil with regular physical activity · Sedentary, overweight adults with risk factors for coronary disease
6 g1.56 g12 weeks—
Fish oil supplementation improves neutrophil function during cancer chemotherapy
2012 · FO · Cancer patients receiving chemotherapy after surgical tumor removal, mainly gastrointestinal cancers; age and sex not stated
2 g400 mg8 weeks—
Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial
2023 · high-DHA diet (intervention) · Preterm infants born before 33 weeks gestation and their breastfeeding mothers; enrolled within 5 days of commencing enteral feeds
3 g900 mg——
Omega-3 polyunsaturated fatty acids supplementation improves memory in first-diagnosed, drug-naïve patients with depression: Secondary analysis of data from a randomized controlled trial
2024 · n-3 PUFAs supplementation · Outpatients with first-diagnosed, drug-naïve depression receiving venlafaxine; age and sex not reported
2.4 g960 mg12 weeks—
Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis--a double-blind placebo controlled study
1993 · Maxepa · Patients with stable mild rheumatoid arthritis requiring NSAID therapy only; age and sex not reported
1.71 g1.14 g1 year—
The effects of omega-3 fatty acids on neuropsychological functioning and brain morphology in mid-life adults: a randomized clinical trial
2020 · fish oil group · Adults aged 30–54 years with low dietary EPA and DHA intake and no stated diagnosed condition
2 g400 mg18 weeks134
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
2015 · ω-3 PUFA group · People aged 13–25 with ultra-high risk for psychosis
2 g480 mg12 weeks40
Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial
2022 · active group · Cognitively healthy adults aged 65 years and older
1 g430 mg2 years30
Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children
2024 · intervention group · Children aged 1–8 years with moderate-to-severe atopic dermatitis
2 g400 mg120 days26
Clinical and microbiological outcomes of subgingival instrumentation supplemented with high-dose omega-3 polyunsaturated fatty acids in periodontal treatment - a randomized clinical trial
2023 · Test group (SRP plus fish oil) · Adults aged 22–70 with generalized stage III or IV periodontitis
20 mL1.8 g26 weeks24
Omega-3 Polyunsaturated Fatty Acids EPA and DHA as an Adjunct to Non-Surgical Treatment of Periodontitis: A Randomized Clinical Trial
2020 · Test group · Adults aged 22–70 with generalized stage III or IV periodontitis
20 mL1.8 g90 days20
An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study (pilot) [ISRCTN22569553]
2004 · Active (fish oil) · University staff aged 18–60 with moderate to high perceived stress
2 g504 mg6 weeks16
Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients
1999 · fish oil group (T) · Patients with hypercholesterolemia, including hyperlipoproteinemia type IIa and IIb; age and sex not reported
216 mg140 mg6 weeks—
Omega-3 and -6 fatty acid supplementation and sensory processing in toddlers with ASD symptomology born preterm: A randomized controlled trial
2017 · treatment group · Children aged 18–38 months, born at ≤29 weeks’ gestation and showing significant ASD symptoms
706 mg225 mg90 days—
Myokine Circulating Levels in Postmenopausal Women with Overweight or Obesity: Effects of Resistance Training and/or DHA-Rich n-3 PUFA Supplementation
2025 · omega-3 group (n-3) · Postmenopausal women aged 55–70 with overweight or obesity (BMI 27.5–35 kg/m²)
3 g1.65 g16 weeks—
Myokine Circulating Levels in Postmenopausal Women with Overweight or Obesity: Effects of Resistance Training and/or DHA-Rich n-3 PUFA Supplementation
2025 · omega-3 + resistance training group (n-3+RT) · Postmenopausal women aged 55–70 with overweight or obesity (BMI 27.5–35 kg/m²)
3 g1.65 g16 weeks—
Fish oil amplifies the effect of propranolol in mild essential hypertension
1990 · Third subgroup: propranolol plus fish oil · Men with mild essential hypertension
9 g1.1 g12 weeks16
Effects of fish oils on ex vivo B-cell responses of obese subjects upon BCR/TLR stimulation: a pilot study
2018 · FO concentrate · Obese men and women with BMI >30
4 g1.2 g12 weeks12
The effects of supplemental fish oil on blood pressure and morning cortisol in normotensive adults: a pilot study
2012 · Fish Oil (FO) · Adults, mean age 35±13 years, normotensive
4 g800 mg6 weeks—
The effect of fish oil supplementation on serum phospholipid fatty acids profile during pregnancy: A double blind randomized controlled trial
2017 · Fish oil supplementation group · Pregnant women aged 18–35 years
1 g120 mg——
Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects
2007 · PS-FO · Men and postmenopausal women aged 30–65 years with mildly overweight hypercholesterolemia
9.6 g3.7 g4 weeks21
The effects of low dose n-3 fatty acids on serum lipid profiles and insulin resistance of the elderly: a randomized controlled clinical trial
2010 · intervention group · Elderly Iranian residents aged 65 or older
1 g120 mg26 weeks—
A self-emulsifying Omega-3 ethyl ester formulation (AquaCelle) significantly improves eicosapentaenoic and docosahexaenoic acid bioavailability in healthy adults
2020 · SEDDS AquaCelle fish oil formulation · Healthy adults
680 mg204 mg1 day—
A self-emulsifying Omega-3 ethyl ester formulation (AquaCelle) significantly improves eicosapentaenoic and docosahexaenoic acid bioavailability in healthy adults
2020 · Unformulated fish oil EE control · Healthy adults
680 mg204 mg1 day—
A Randomized Double-Blinded, Placebo-Controlled Trial Investigating the Effect of Fish Oil Supplementation on Gene Expression Related to Insulin Action, Blood Lipids, and Inflammation in Gestational Diabetes Mellitus-Fish Oil Supplementation and Gestational Diabetes
2018 · omega-3 · Women aged 18–40 with gestational diabetes mellitus and no prior history of diabetes
2 g240 mg6 weeks20
Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y
2001 · Fish oil group · Healthy adults aged 55–75 years
720 mg280 mg12 weeks—
Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease
2017 · fish oil group · Adults with stable, mild or severe claudication due to peripheral arterial disease (Rutherford Class 1 to 3); primarily male, in their mid-sixties
4.4 g1.8 g30 days40
Comparative Bioavailability of DHA and EPA from Microalgal and Fish Oil in Adults
2025 · fish oil arm · Adults aged 21–82, men and women, with fasting triglycerides of 149–450 mg/dL
1.16 g820 mg14 weeks20
Wax Ester Rich Oil From The Marine Crustacean, Calanus finmarchicus, is a Bioavailable Source of EPA and DHA for Human Consumption
2016 · Lovaza ethyl ester condition · Healthy adults; age and sex not specified
465 mg375 mg1 day18
Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans
2004 · DHA · Healthy human subjects; age and sex not specified
4.9 g4.9 g4 weeks—
DHA-rich Fish Oil Increases the Omega-3 Index and Lowers the Oxygen Cost of Physiologically Stressful Cycling in Trained Individuals
2017 · DHA-rich tuna fish oil (FO) · trained males; age and health condition not specified
560 mg560 mg8 weeks—
Prevention of Potential Adverse Metabolic Effects of a Supplementation with Omega-3 Fatty Acids Using a Genetic Score Approach
2020 · n-3 PUFA supplementation · Adults; age, sex, and health condition not specified
5 g1.1 g6 weeks210
Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
2017 · Lovaza · Adults aged 36–80 with stable coronary artery disease and overweight/obesity or metabolic-syndrome features; included participants with and without type 2 diabetes
3.36 g1.5 g1 year147
Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements
2017 · fish oil group · Adults aged 50 and older with symptomatic lower-extremity peripheral arterial disease and intermittent claudication
4.4 g1.8 g30 days40
DHA-enriched fish oil reduces insulin resistance in overweight and obese adults
2020 · FO (fish oil) intervention · Men and women with abdominal obesity, without diabetes; mean age 50.9 ± 12.7 years
2 g860 mg12 weeks38
Efficacy of fish oil on serum of TNF α , IL-1 β , and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b
2013 · fish oil group · Adults aged 18–55 with relapsing-remitting multiple sclerosis, treated with interferon beta-1b
4 g1.6 g1 year25
Metabolic and endocrine effects of long-chain versus essential omega-3 polyunsaturated fatty acids in polycystic ovary syndrome
2011 · fish oil · Women aged 20–45 with PCOS and BMI 25–45 kg/m²
2.15 g1.45 g6 weeks21
DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men
2009 · DHA oil group · Men aged 39–66 with hypertriglyceridemia
7.5 g3 g90 days17
Fish oil supplementation induces expression of genes related to cell cycle, endoplasmic reticulum stress and apoptosis in peripheral blood mononuclear cells: a transcriptomic approach
2014 · FO group · Healthy men and women aged 18–50 years
8 g900 mg7 weeks17
Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial)
2019 · fish oil group · Men aged 50 years or older with peripheral artery disease and intermittent claudication
4.4 g1.8 g90 days11
Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial)
2019 · fish oil group · Men aged 50 years or older with peripheral artery disease and intermittent claudication
4.4 g1.8 g90 days11
Different gene expression profiles in normo- and dyslipidemic men after fish oil supplementation: results from a randomized controlled trial
2012 · FO-N (normolipidemic fish oil group) · Men aged 29–51 years with normolipidemia
2.7 g1.14 g12 weeks10
Different gene expression profiles in normo- and dyslipidemic men after fish oil supplementation: results from a randomized controlled trial
2012 · FO-D (dyslipidemic fish oil group) · Men aged 29–51 years with dyslipidemia
2.7 g1.14 g12 weeks9
Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects
1994 · fish oil · Subjects without cystic fibrosis; mean age 13.4 years
8 g2.2 g6 weeks8
Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects
1994 · fish oil · Patients with cystic fibrosis and pancreatic insufficiency; mean age 12.2 years
8 g2.2 g6 weeks7
Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia
2020 · n-3 supplementation · Six subjects with hypertriglyceridemia; age and sex not reported
3 g240 mg60 days6
Consumption of fish oil leads to prompt incorporation of eicosapentaenoic acid into colonic mucosa of patients prior to surgery for colorectal cancer, but has no detectable effect on epithelial cytokinetics
1999 · FO group · Adults with colonic carcinoma awaiting surgery; ages and sex distribution as reported in the abstract
4 g1 g12 days—
Encapsulated fish oil enriched in alpha-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions
2000 · fish oil (FO) · Healthy subjects; age and sex not specified
9 g1.1 g12 weeks—
Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians
2004 · Fish-oil group · British Indo-Asian Sikhs and Europeans; adults, age and weight matched between ethnic groups
4 g1 g12 weeks—
ALOX5 gene variants affect eicosanoid production and response to fish oil supplementation
2011 · fish oil · African American adults aged 20–59 years, 68% female; no specific condition stated
5 g1 g——
[Effect on the lipid profile of diet supplemented with fish oil concentrate]
1990 · n-3 treated group · male and female patients with cholesterol values higher than 7.0 mmol/l
6 g1.5 g12 weeks—
Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults
2020 · EPA-rich fish oil · Healthy adults aged 23–44, without chronic or serious disease
12 g1.5 g8 weeks—
Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults
2020 · DHA-rich fish oil · Healthy adults aged 23–44, without chronic or serious disease
12 g3.6 g8 weeks—
The Impacts of Fish Oil and/or Probiotic Intervention on Low-Grade Inflammation, IGFBP-1 and MMP-8 in Pregnancy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
2020 · fish oil + placebo · Overweight or obese pregnant women at increased risk for gestational diabetes
2.4 g1.9 g——
The Impacts of Fish Oil and/or Probiotic Intervention on Low-Grade Inflammation, IGFBP-1 and MMP-8 in Pregnancy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
2020 · fish oil + probiotics · Overweight or obese pregnant women at increased risk for gestational diabetes
2.4 g1.9 g——
Modification of subcutaneous white adipose tissue inflammation by omega-3 fatty acids is limited in human obesity-a double blind, randomised clinical trial
2022 · Fish oil · Adults aged 18–65 years, healthy normal-weight participants and participants living with obesity without diagnosed metabolic complications
3 g800 mg12 weeks—
Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels
1996 · fish oil group · Healthy male university students
4 g950 mg15 weeks—
A Mixed Flavonoid-Fish Oil Supplement Induces Immune-Enhancing and Anti-Inflammatory Transcriptomic Changes in Adult Obese and Overweight Women-A Randomized Controlled Trial
2016 · Q-Mix · Women aged 40–70 years who were overweight or obese (BMI ≥25 kg/m²), without the listed major diseases
200 mg90 mg10 weeks24
The immunomodulatory effects of fish-oil supplementation in elite paddlers: A pilot randomized double blind placebo-controlled trial
2015 · fish-oil capsules · male elite paddlers undertaking an increasing exercise program
6 g1.2 g4 weeks11
Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration
2014 · Group 1 (Vitalux plus Omega-3) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment
1.05 g200 mg—10
Synbiotic Bacillus megaterium DSM 32963 and n-3 PUFA Salt Composition Elevates Pro-Resolving Lipid Mediator Levels in Healthy Subjects: A Randomized Controlled Study
2024 · Fish oil group · Healthy men and women aged 30–75 years, selected as at-risk individuals with omega-3 index ≤6.5% and elevated AGEs and/or hsCRP
180 mg120 mg4 weeks—
Red Blood Cell Omega-3 Fatty Acid Composition and Psychotropic Drug Use in Older Adults: Results from the MAPT Study
2019 · PUFA supplementation alone · Adults aged 70 years or older with a memory complaint, an instrumental activity limitation, or slow walking speed
800 mg800 mg3 years401
Red Blood Cell Omega-3 Fatty Acid Composition and Psychotropic Drug Use in Older Adults: Results from the MAPT Study
2019 · PUFA supplementation + multidomain intervention · Adults aged 70 years or older with a memory complaint, an instrumental activity limitation, or slow walking speed
800 mg800 mg3 years399